Met Life Investment Management, LLC Unity Biotechnology, Inc. Transaction History

Met Life Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.94 - $12.43 $43,153 - $182,447	-14,678 Closed	0 $0
Q2 2020 May 24, 2024	BUY	$5.28 - $9.67 $77,499 - $141,936	14,678 New	14,678 $127 Million
Q2 2020 Jun 26, 2023	BUY	$5.28 - $9.67 $77,499 - $141,936	14,678 New	14,678 $127,000
Q2 2020 Mar 22, 2023	BUY	$5.28 - $9.67 $13,817 - $25,306	2,617 Added 21.7%	14,678 $127,000
Q2 2020 Aug 14, 2020	BUY	$5.28 - $9.67 $77,499 - $141,936	14,678 New	14,678 $127,000
Q2 2019 Jul 12, 2023	BUY	$7.59 - $10.21 $111,648 - $150,189	14,710 New	14,710 $140 Million
Q1 2019 May 15, 2019	SELL	$7.65 - $16.66 $92,266 - $200,936	-12,061 Closed	0 $0
Q4 2018 Jul 13, 2023	BUY	$10.76 - $17.25 $129,776 - $208,052	12,061 New	12,061 $196,000
Q4 2018 Mar 22, 2023	BUY	$10.76 - $17.25 $129,776 - $208,052	12,061 New	12,061 $196,000
Q4 2018 Feb 14, 2019	BUY	$10.76 - $17.25 $129,776 - $208,052	12,061 New	12,061 $196,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14.5M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.